MLICM
PTX

Metropolitan Life Insurance Company (MetLife)’s Pernix Therapeutics Holdings, Inc. PTX Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio PTX Stock Details PTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-2,826
Closed -$89K – 2678
2015
Q3 		$89K Buy
2,826
+266
+10% +$12.7K ﹤0.01% 2594
2015
Q2 		$152K Sell
2,560
-138
-5% -$9.73K ﹤0.01% 2540
2015
Q1 		$288K Hold
2,698
– – ﹤0.01% 1867
2014
Q4 		$253K Hold
2,698
– – ﹤0.01% 2240
2014
Q3 		$207K Hold
2,698
– – ﹤0.01% 2343
2014
Q2 		$242K Buy
+2,698
New +$165K ﹤0.01% 2372

Other funds holding PTX

BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
ECP
Elk Creek Partners Denver, Colorado $582M AUM 10.23% 1-Year Est. Return
AC
Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s PTX Position: Q4 2015 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Pernix Therapeutics Holdings, Inc. (PTX) in Q4 2015, closing a stake of 2,826 shares — an estimated $89K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in PTX in Q2 2014 and held it in 6 quarters. The position peaked at $288K in Q1 2015. 101 funds tracked by Wall St. Rank hold PTX as of Q4 2015.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining Pernix Therapeutics Holdings, Inc. position as of Q4 2015 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 2,826 Pernix Therapeutics Holdings, Inc. shares in Q4 2015, an estimated $89K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in Pernix Therapeutics Holdings, Inc. in Q2 2014 and held it in 6 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s Pernix Therapeutics Holdings, Inc. position peaked at $288K in Q1 2015.
  • 101 funds tracked by Wall St. Rank held Pernix Therapeutics Holdings, Inc. as of Q4 2015.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q4 2015, filed 11 Feb 2016.